Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuya Yasuo

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Chemical Information and Modeling|April 28, 2009
Structure-based CoMFA as a predictive model - CYP2C9 inhibitors as a test caseKazuya Yasuo, Noriyuki Yamaotsu, Hiroaki Gouda, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2025
A cap-dependent endonuclease inhibitor acts as a potent antiviral agent against La Crosse virus infectionKei Konishi, Yoshiyuki Taoda, Manabu Igarashi, et al.
Bioorganic & Medicinal Chemistry|August 27, 2021
A novel tricyclic β-lactam exhibiting potent antibacterial activities against carbapenem-resistant Enterobacterales: Synthesis and structure-activity-relationshipsJun Sato, Hiroki Kusano, Toshiaki Aoki, et al.
Journal of Medicinal Chemistry|August 7, 2019
Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as Potent Inhibitors of Influenza Cap-dependent EndonucleaseMasayoshi Miyagawa, Toshiyuki Akiyama, Yoshiyuki Taoda, et al.
Journal of Medicinal Chemistry|August 13, 2024
Dual 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> Receptor Inverse Agonist That Affords In Vivo Antipsychotic Efficacy with Minimal hERG Inhibition for the Treatment of Dementia-Related PsychosisTakuya Oguma, Kohei Jino, Kenji Nakahara, et al.
Journal of Medicinal Chemistry|May 3, 2013
Indazole-based potent and cell-active Mps1 kinase inhibitors: rational design from pan-kinase inhibitor anthrapyrazolone (SP600125)Ken-ichi Kusakabe, Nobuyuki Ide, Yataro Daigo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Diaminopyridine-based potent and selective mps1 kinase inhibitors binding to an unusual flipped-Peptide conformationKen-Ichi Kusakabe, Nobuyuki Ide, Yataro Daigo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Chemical Information and Modeling|April 28, 2009
Structure-based CoMFA as a predictive model - CYP2C9 inhibitors as a test caseKazuya Yasuo, Noriyuki Yamaotsu, Hiroaki Gouda, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2025
A cap-dependent endonuclease inhibitor acts as a potent antiviral agent against La Crosse virus infectionKei Konishi, Yoshiyuki Taoda, Manabu Igarashi, et al.
Bioorganic & Medicinal Chemistry|August 27, 2021
A novel tricyclic β-lactam exhibiting potent antibacterial activities against carbapenem-resistant Enterobacterales: Synthesis and structure-activity-relationshipsJun Sato, Hiroki Kusano, Toshiaki Aoki, et al.
Journal of Medicinal Chemistry|August 7, 2019
Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as Potent Inhibitors of Influenza Cap-dependent EndonucleaseMasayoshi Miyagawa, Toshiyuki Akiyama, Yoshiyuki Taoda, et al.
Journal of Medicinal Chemistry|August 13, 2024
Dual 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> Receptor Inverse Agonist That Affords In Vivo Antipsychotic Efficacy with Minimal hERG Inhibition for the Treatment of Dementia-Related PsychosisTakuya Oguma, Kohei Jino, Kenji Nakahara, et al.
Journal of Medicinal Chemistry|May 3, 2013
Indazole-based potent and cell-active Mps1 kinase inhibitors: rational design from pan-kinase inhibitor anthrapyrazolone (SP600125)Ken-ichi Kusakabe, Nobuyuki Ide, Yataro Daigo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Diaminopyridine-based potent and selective mps1 kinase inhibitors binding to an unusual flipped-Peptide conformationKen-Ichi Kusakabe, Nobuyuki Ide, Yataro Daigo, et al.
Pageof 1